Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Viridian Therapeutics, Inc. - Common Stock (NQ:VRDN)

32.85 -0.18 (-0.54%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Viridian Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
It's time for another breakdown of the biggest pre-market stock movers as we check out all of the shares rising and falling on Tuesday! 
Via InvestorPlace
News headline image
JetBlue Airways, VOXX International And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
U.S. stock futures traded slightly higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
News headline image
Viridian Announces Positive Data from Ongoing Phase 1/2 Trial Evaluating VRDN-001 in Patients with Chronic Thyroid Eye Disease (TED)
From Viridian Therapeutics, Inc.
Via Business Wire
News headline image
11 Analysts Have This to Say About Viridian Therapeutics ↗
 
Via Benzinga
News headline image
Analyst Ratings for Viridian Therapeutics ↗
 
Via Benzinga
News headline image
Recap: Viridian Therapeutics Q1 Earnings ↗
 
Via Benzinga
News headline image
Earnings Outlook For Viridian Therapeutics ↗
 
Via Benzinga
News headline image
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
From Viridian Therapeutics, Inc.
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2023 ↗
 
Via Benzinga
News headline image
Expert Ratings for Viridian Therapeutics ↗
 
Via Benzinga
News headline image
Viridian Therapeutics Announces Presentations at the 2023 Annual Meeting of the Endocrine Society
From Viridian Therapeutics, Inc.
Via Business Wire
News headline image
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Viridian Therapeutics, Inc.
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 30, 2023 ↗
 
Via Benzinga
News headline image
Analyst Expectations for Viridian Therapeutics's Future ↗
 
Via Benzinga
News headline image
Viridian Therapeutics Earnings Perspective: Return On Capital Employed ↗
 
Via Benzinga
News headline image
Analyst Expectations for Viridian Therapeutics's Future ↗
 
Via Benzinga
News headline image
Viridian Therapeutics Earnings Preview ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 9, 2023 ↗
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.17 per share on revenue of $440.16 million. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2023 ↗
 
Via Benzinga
News headline image
The Latest Analyst Ratings for Viridian Therapeutics ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For April 17, 2023 ↗
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For March 8, 2023 ↗
Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million. 
Via Benzinga
News headline image
Viridian's Thyroid Eye Disease Candidate Shows Promise At Lower Doses ↗
 
Via Benzinga
Viridian Therapeutics Earnings Perspective: Return On Capital Employed ↗
 
Via Benzinga
News headline image
Viridian Therapeutics' Lead Product Has An Opportunity To Differentiate, Analyst Sees 85% Upside ↗
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2022 ↗
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2022 ↗
 
Via Benzinga
News headline image
Workday, XPeng, Titan Machinery And Some Other Big Stocks Moving Higher On Wednesday ↗
U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Why Leslie's Shares Are Trading Lower By Over 9%? Here Are 60 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Biophytis S.A. (NASDAQ: BPTS) shares jumped 114% to $0.7496. Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) rose 74.1% to $0.2115. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.